SOLAGRAN LIMITED
SLA - Quarterly Newsletter - Mr Denis Kilroy, Executive Director
Thu, 10 May 2007 02:30PM
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Mr Denis Kilroy
Thu, 10 May 2007
02:30PM Australia/NSW
Boardroom Radio Tools
Select a tab above to display more information
SOLAGRAN LIMITED (SLA)
ASX code: SLA
Website: http://www.solagran.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Research and development of bio-medical products used in the treatment of cirrhosis, chronic hepatitis and other liver conditions.
Address:
492 St Kilda Road, Level 11
MELBOURNE
VIC
Phone: (03) 9820 2699
Fax: (03) 9820 3155
Executives & Directors
Dr Vagif Soultanov , Executive Chairman
Mr Peter Stedwell , Executive Director
Mr Denis Kilroy , Executive Director
Mr Charles Pellegrino , Executive Director
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
SOLAGRAN LIMITED (SLA) Events
SOLAGRAN LIMITED (SLA)
| Boardroom Radio Broadcast | Tue, 11 Nov 2008 |
| Short Form Prospectus | Fri, 7 Nov 2008 |
| Appendix 3B | Fri, 7 Nov 2008 |
| Appendix 3B | Thu, 6 Nov 2008 |
| Non-Renounceable Pro Rata Rights Issue | Thu, 6 Nov 2008 |
| Appendix 4C - quarterly | Fri, 31 Oct 2008 |
| Commercialisation Update | Wed, 29 Oct 2008 |
| Notice of Annual General Meeting | Wed, 29 Oct 2008 |
| Non-Renounceable Pro Rata Rights Issue | Wed, 29 Oct 2008 |
| 2008 Annual Report | Tue, 21 Oct 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.






















